Connor, Clark & Lunn Investment Management Ltd. Novo Nordisk A S Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 57,477 shares of NVO stock, worth $5.22 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
57,477
Previous 63,912
10.07%
Holding current value
$5.22 Million
Previous $7.61 Million
35.03%
% of portfolio
0.02%
Previous 0.04%
Shares
26 transactions
Others Institutions Holding NVO
# of Institutions
1,882Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.81 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.41 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.18 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.15 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.11 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $205B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...